In patients with liver cirrhosis who had not developed HCC and who had taken NADs for at least 6 months, serum albumin levels were measured in 54 lactitol and 70 lactulose patients from 6 months before taking NADs to 6 months after taking NADs (Table 5). This evidence concerns the gene ALB and hepatocellular carcinoma.